United States · FDA National Drug Code directory

Dexlansoprazole delayed release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 51407-746_547576e8-2b38-b64b-e063-6294a90a52cc
Product NDC: 51407-746
Form: CAPSULE, DELAYED RELEASE
Composition / generic term: dexlansoprazole
Labeler: Golden State Medical Supply, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20220916
Source listing expiry: 20271231

Source-listed ingredients

DEXLANSOPRAZOLE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (51407-746-30) · 51407-746-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →